1. Home
  2. JMM vs AADI Comparison

JMM vs AADI Comparison

Compare JMM & AADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JMM
  • AADI
  • Stock Information
  • Founded
  • JMM 1988
  • AADI 2011
  • Country
  • JMM United States
  • AADI United States
  • Employees
  • JMM N/A
  • AADI N/A
  • Industry
  • JMM Trusts Except Educational Religious and Charitable
  • AADI Biotechnology: Pharmaceutical Preparations
  • Sector
  • JMM Finance
  • AADI Health Care
  • Exchange
  • JMM Nasdaq
  • AADI Nasdaq
  • Market Cap
  • JMM 56.8M
  • AADI 77.5M
  • IPO Year
  • JMM N/A
  • AADI N/A
  • Fundamental
  • Price
  • JMM $6.04
  • AADI $2.80
  • Analyst Decision
  • JMM
  • AADI Hold
  • Analyst Count
  • JMM 0
  • AADI 3
  • Target Price
  • JMM N/A
  • AADI $1.75
  • AVG Volume (30 Days)
  • JMM 16.1K
  • AADI 256.8K
  • Earning Date
  • JMM 01-01-0001
  • AADI 03-12-2025
  • Dividend Yield
  • JMM 5.44%
  • AADI N/A
  • EPS Growth
  • JMM N/A
  • AADI N/A
  • EPS
  • JMM N/A
  • AADI N/A
  • Revenue
  • JMM N/A
  • AADI $25,070,000.00
  • Revenue This Year
  • JMM N/A
  • AADI $8.43
  • Revenue Next Year
  • JMM N/A
  • AADI $5.41
  • P/E Ratio
  • JMM N/A
  • AADI N/A
  • Revenue Growth
  • JMM N/A
  • AADI 7.80
  • 52 Week Low
  • JMM $5.29
  • AADI $1.21
  • 52 Week High
  • JMM $6.10
  • AADI $3.81
  • Technical
  • Relative Strength Index (RSI)
  • JMM 49.12
  • AADI 45.72
  • Support Level
  • JMM $6.02
  • AADI $2.66
  • Resistance Level
  • JMM $6.16
  • AADI $2.98
  • Average True Range (ATR)
  • JMM 0.08
  • AADI 0.14
  • MACD
  • JMM 0.00
  • AADI -0.06
  • Stochastic Oscillator
  • JMM 45.22
  • AADI 24.48

About JMM Nuveen Multi-Market Income Fund (MA)

Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Share on Social Networks: